Abstract
The aim of this study was to evaluate whether hepatic arterial infusion concurrent chemoradiotherapy (CCRT) could improve overall survival (OS) in patients with locally advanced hepatocellular carcinoma (LAHCC). Two databases were reviewed from Yonsei Cancer Center (YCC) and Korean Liver Cancer Study Group (KLCSG) nationwide multi-center hepatocellular carcinoma (HCC) cohort. The CCRT group included 106 patients, with stage III-IV, Child-Pugh classification A, Eastern Cooperative Oncology Group performance status 0 or 1, who underwent definitive CCRT as the initial treatment at YCC. We used propensity score matching to adjust for seven clinical factors, including age, tumor size, TNM stage by the Liver Cancer Study Group of Japan, T stage, Barcelona Clinic Liver Cancer (BCLC) staging system, etiology of HCC, and portal vein invasion, which all differed significantly in the two databases. From the KLCSG cohort enrolled at 32 institutions, 106 patients for the non-CCRT group were defined. After propensity score matching, all patient characteristics were balanced between the two groups. The CCRT group had better OS (median, 11.4) than the non-CCRT group (6.6 months, p=0.02). In multivariate analyses for all patients, CCRT (hazard ...Continue Reading
References
Dec 1, 1989·International Journal of Radiation Oncology, Biology, Physics·G B StillwagonE K Fishman
Feb 24, 2001·Clinical Oncology : a Journal of the Royal College of Radiologists·UNKNOWN Regional Thyroid Cancer Group
Aug 12, 2003·International Journal of Radiation Oncology, Biology, Physics·Kazunari YamadaKazuro Sugimura
Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
Nov 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edgar Ben-JosefTheodore S Lawrence
Nov 4, 2006·The Lancet Oncology·Anne FleissigLesley Fallowfield
Dec 6, 2006·International Journal of Radiation Oncology, Biology, Physics·Françoise MornexPhilippe Merle
Dec 1, 2007·Epidemiology·Erik von ElmUNKNOWN STROBE Initiative
Jul 11, 2008·Cancer·Kwang-Hyub HanChae Yoon Chon
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Sep 18, 2008·Liver International : Official Journal of the International Association for the Study of the Liver·Jinsil SeongChul Joo Han
Dec 20, 2008·The Lancet Oncology·Ann-Lii ChengZhongzhen Guan
Nov 17, 2009·Surgical Oncology Clinics of North America·Adam C Yopp, William R Jarnagin
Apr 14, 2010·Journal of the National Cancer Institute. Monographs·Mary L FennellAndrew Salner
Mar 5, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jordi BruixUNKNOWN American Association for the Study of Liver Diseases
May 31, 2011·International Journal of Radiation Oncology, Biology, Physics·Sang Min YoonDong Jin Suh
Oct 14, 2011·Future Oncology·Mersiha HadziahmetovicArnab Chakravarti
Oct 20, 2012·Cancer Chemotherapy and Pharmacology·Mi Sung ParkJinsil Seong
May 28, 2013·PharmacoEconomics·Tan ChongqingZhao Ziying
Jun 29, 2013·Seminars in Oncology·Nicholas G ZaorskyRobert B Den
Dec 18, 2013·Liver International : Official Journal of the International Association for the Study of the Liver·Kyung Hwan KimJinsil Seong
May 9, 2014·Journal of Cancer Research and Clinical Oncology·Hong In YoonJinsil Seong
Jun 12, 2014·Annals of Surgical Oncology·Hyung Soon LeeBeom Kyung Kim
Citations
Feb 14, 2018·Clinical and Molecular Hepatology·Seo Hee Choi, Jinsil Seong
Nov 8, 2017·Oncotarget·In Rae ChoJun Yong Park
Aug 4, 2016·Oncotarget·Hong In YoonJinsil Seong
Aug 16, 2017·Radiation Oncology·Ja Kyung KimKwan Sik Lee
Aug 30, 2016·World Journal of Gastroenterology : WJG·Jeong Il Yu, Hee Chul Park